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A B S T R A C T
Purpose: We investigated neurologists’ experience of participating in the large CODES trial involving around 900
adults with dissociative seizures which subsequently evaluated the effectiveness of tailored cognitive beha-
vioural therapy (CBT) plus standardised medical care versus standardised medical care alone in 368 patients
with dissociative seizures.
Method: We asked all neurologists referring patients with dissociative seizures to the CODES study to complete a
43-item online survey. This examined neurologists’ (i) demographics, (ii) knowledge of dissociative seizures
before and after their involvement in the CODES trial, (iii) clinical practice before, during and since their in-
volvement, and (iv) their experience of the CODES trial.
Results: Forty-three (51%) neurologists completed the questionnaire. Only about half of neurologists could make
referrals to psychological intervention specific for dissociative seizures before and after the trial. One-third of
doctors reported having changed their referral practice following their involvement. The majority (> 69%)
agreed that patient satisfaction with different aspects of the trial was very high, and 83.7% thought that it was
easy to recruit patients for the study. Over 90% agreed they would like the treatment pathway to continue.
Respondents found different elements of the trial useful, in particular, the patient factsheet booklet (98%),
diagnosis communication advice (93%) and the CBT package (93%).
Conclusions: Neurologists participating in CODES generally found it easy to recruit patients and perceived pa-
tient satisfaction as very high. However, 46.5% of neurologists could not offer psychotherapy once the trial had
finished, suggesting that problems with lack of access to psychological treatment for dissociative seizures persist.
1. Introduction
Dissociative seizures—also referred to as psychogenic non-epileptic
seizures— account for about 20% of referrals to seizure clinics [1].
Traditionally, neurologists have viewed their role as limited to the di-
agnosis of dissociative seizures rather than the treatment of this dis-
order [2]. While there is currently no clear evidence base, expert opi-
nion has favoured psychotherapeutic treatments [3], although most
patients perceive their dissociative seizures as a problem which is lar-
gely “physical” [4]. Consequently, many patients resist neurologists’
proposal to pursue a psychotherapeutic treatment approach [5,6], re-
enforcing the views of health professionals that patients with dis-
sociative seizures are particularly challenging or “difficult” [7].
We took advantage of the CODES trial on dissociative seizures to
explore neurologists’ attitudes and experiences of treating patients with
the condition in the context of this clinical study. Whilst the CODES
trial primarily explored the benefit of adding cognitive behavioural
therapy to standardised medical care, participation in recruitment
made it necessary for neurologists to be more firmly involved in a
treatment pathway for patients with dissociative seizures: They had to
communicate the diagnosis in a prescribed fashion, refer patients to
participating psychiatrists, and were encouraged to offer neurological
https://doi.org/10.1016/j.seizure.2019.05.020
Received 18 March 2019; Received in revised form 3 May 2019; Accepted 20 May 2019
⁎ Corresponding author at: Dept of Psychology, Institute of Psychiatry, Psychology and Neuroscience, De Crespigny Park, London, SE5 8AF, UK.
E-mail addresses: ghrawlings1@sheffield.ac.uk (G.H. Rawlings), iain.perdue@kcl.ac.uk (I. Perdue), laura.goldstein@kcl.ac.uk (L.H. Goldstein),
A.Carson@ed.ac.uk (A.J. Carson), Jon.Stone@ed.ac.uk (J. Stone), m.reuber@sheffield.ac.uk (M. Reuber).
Seizure: European Journal of Epilepsy 71 (2019) 8–12
1059-1311/ © 2019 The Authors. Published by Elsevier Ltd on behalf of British Epilepsy Association. This is an open access article under the CC BY license 
(http://creativecommons.org/licenses/BY/4.0/).
T
follow-up as part of the standardised care package rather than to dis-
charge them at the point of diagnosis [8].
The aim of the present study was to investigate neurologists’ ex-
perience with this deeper involvement in the treatment of dissociative
seizures, to explore their knowledge of dissociative seizures and clinical
practice for patients with the condition before and since their in-
volvement in the trial, as well as their opinions on the utility of the
various components of the CODES intervention.
2. Methods
The CODES trial is a United Kingdom (UK)-based multicentre,
pragmatic, parallel group randomised controlled trial designed to
evaluate the clinical and cost-effectiveness of specifically tailored cog-
nitive behavioural therapy (CBT) plus standardised medical care versus
standardised medical care alone for adults with dissociative seizures. In
total, neurologists identified 901 patients with dissociative seizures as
possible candidates for the CODES study over a 29-month period; of
these 698 were recruited to the first stage of the study. Ultimately, 368
patients entered one of the two treatment arms after reassessment for
suitability for randomisation by a psychiatrist. Self-report measures
were completed at baseline, 6 and 12 months post-randomisation. The
protocol and statistical analysis plan for the trial have been published
elsewhere [8,9].
2.1. Neurologists’ role in the CODES trial
In the CODES trial, standardised medical care first involved neu-
rologists making an assessment to determine the nature of the patients’
seizures. Neurologists were encouraged to follow their usual diagnostic
process (i.e. patient history, witness history, physical assessment, brain
imaging if appropriate and where possible, video-electro-
encephalography (video-EEG)). If the diagnosis of dissociative seizures
was not supported by the video-EEG recording of a typical seizure, the
evidential basis of the diagnosis was reviewed by an independent
neurologist who was given access to all relevant clinical data.
Neurologists participating in CODES also had to explain the diagnosis to
potential participants. Their explanation of dissociative seizures was
expected to cover the same topics as the factsheet given to patients after
their appointment (see Neurology leaflet at http://www.codestrial.org/
information-booklets/4579871164) : i) what dissociative seizures are,
how the tests confirm the diagnosis, that the episodes are genuine, the
disorder is common and treatable; ii) the underlying mechanism of
dissociative seizures specific to the presenting symptoms and experi-
ences; and iii) the rationale for making a referral to a psychiatrist.
Neurologists had to give all potential participants an information sheet
describing the trial and to take consent from all potential participants to
pass on their contact details to research staff. Patients were then con-
tacted by CODES researchers who offered more information about the
study and obtained written consent to the initial observational part of
the study. Neurologists had to refer all patients who had agreed to take
part in the CODES trial to a participating psychiatrist who was expected
to contribute to patients’ further standardised care as well as assessing
their suitability for entry into the second phase of CODES in which
around 53% of all participants were randomised to standardised care
with or without additional CBT. Neurologists were encouraged to offer
CODES patients at least one follow-up visit in the neurology department
[8]. Participant information sheets for both phases of the CODES trial
are found in supplementary files 1 and 2.
2.2. Recruitment
Eighty-four neurologists/epilepsy specialists were invited to take
part in the current study via email (all of the 91 neurologists/epilepsy
specialists involved in the CODES trial were initially contacted; how-
ever, the email addresses of seven were no longer functioning). We used
an online survey tool (Bristol Online Survey Tool) to distribute a pur-
pose-designed, 43-item questionnaire (see supplementary file 3). A re-
minder to complete the questionnaire was sent to all neurologists two
weeks after the initial invitation. All data were provided anonymously;
no personal identifiers were gathered.
2.3. Questionnaire (see supplementary file 3)
The questionnaire was created by all co-authors. The questions ex-
plored: (i) respondents’ demographics (age, gender, current role, years
of clinical experience in neurology, and number of patients with dis-
sociative seizures diagnosed per month and under their current care –
6-items); (ii) knowledge of dissociative seizures and treatments before
and after their involvement in the CODES trial (4-items); (iii) clinical
practice before, during and since their involvement in the trial (22-
items); and (iv) experience of using CODES-related components (11-
items).
Qualitative (i.e. open-ended questions) and quantitative data (i.e.
Likert scales with multiple options – 5 = Strongly Agree, 4 = Agree, 3
= Neither Agree nor Disagree, 2 = Disagree, 1 = Strongly Disagree)
collection methods were used.
2.4. Data analysis
All data were exported to an Excel datasheet. For quantitative data,
descriptive statistics were used (M=median, IQR= interquartile
range). To compare self-report scores before and after involvement in
the CODES trial, because the data were ordinal, the Wilcoxon signed
ranks test was used. An alpha value of 0.05 was used for all statistical
analysis. Data was analysed using SPSS 24. For qualitative data, text
was grouped thematically.
3. Results
3.1. Respondents’ demographics
Overall, 43/84 (51%) participating neurologists completed the
questionnaire. Forty were consultant neurologists. Sixty percent were
male, 82% were aged between 41–60 years. Respondents had a median
of 18 years (IQR=9) of experience in neurology. They estimated the
median number of patients with dissociative seizures they typically
diagnosed as 3 per month (IQR=3) and the median number of patients
with dissociative seizures under their care at any one time as 20
(IQR=40.5).
3.2. Knowledge of dissociative seizures
Doctors self-reported a good level of knowledge of dissociative
seizures (i.e. aetiology, diagnosis, treatment, management and prog-
nosis) before their involvement in the CODES study (M=4, IQR=1),
which did not increase significantly through their involvement in the
trial overall (M=5 IQR=1, p= 0.76). Similarly, respondents re-
ported having a good level of knowledge of how psychological inter-
vention may help patients with dissociative seizures before (M=4,
IQR=1) and after the trial (M=4, IQR=1, p=0.67).
3.3. Clinical practice for dissociative seizures
Doctors reported that they already felt confident overall when
managing a patient with dissociative seizures before the trial (M=4,
IQR=2). Their rating did not change as a result of their involvement in
the CODES study (M=4, IQR=1, p=0.1). Fourteen doctors reported
that, while taking part, they were more likely to consider dissociative
seizures as a potential diagnosis at an earlier stage than they might have
previously done (M=3, IQR=2).
About half (53.5%) of the respondents reported having personally
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been able to refer patients directly for psychological intervention spe-
cifically for dissociative seizures before the trial (i.e. to a specialist who
knew about the condition and could provide effective treatment). This
figure did not change once CODES had finished. Service availability was
important; doctors who had access to psychological intervention spe-
cific for dissociative seizures before the trial started estimated that they
referred an average of 78% of their patients. The equivalent estimate
from those unable to refer patients directly was 12%. One respondent
explained: “We didn’t have a specific service so I mostly muddled along on
my own apart from some [patients] who I sent to Liaison Psychiatry or
psychologists in other Trusts.”
As would be expected, before CODES, doctors differed in their re-
ferral practice (Table 1). The majority referred patients with dis-
sociative seizures to psychological intervention directly or referred
patients to another professional who might then make a referral for
psychological intervention.
Around one third of neurologists explained that participating in the
CODES study had changed their practice in relation to referring patients
for psychological intervention. This included: more, earlier or direct
referral; and the establishment of a dissociative seizures pathway
within their organisation directly “on the back of the CODES study”.
Some of the doctors who had not changed their practice explained that
they already had a “very well developed local specialised psychotherapy
service [for dissociative seizures]” or they “still can’t refer to psy-
chotherapy [for dissociative seizures]” suggesting that they were unable
to change their practice once the study had ended. One doctor reported
that his/her referral practice had not changed but “the time [for pa-
tients] to be seen is getting longer… By highlighting the diagnosis to other
clinicians [and therefore increasing the number of patients being diag-
nosed with the condition] yet not increasing resources to deal with them,
my patients now have to wait even longer to be seen”. The ability to refer
patients who lived outside of the practice area to psychological inter-
vention during the trial was also a benefit: “During the course of the study
I was able to refer patients to our psychotherapy programme if they had been
referred from out of area. Before and since CODES I have not been able to do
this”.
Only 16% of respondents indicated that their participation in the
CODES study had changed their referral practices to psychiatrists/
neuropsychiatrists. The majority of doctors agreed with the involve-
ment of psychiatry for all patients with dissociative seizures before and
after their involvement in the CODES study (M=4 IQR=2, M=4,
IQR=1, p=0.1). Having said that, before their involvement in
CODES, only 55% (M=60, IQR=85) of the neurologists referred
patients with dissociative seizures to a psychiatrist/ neuropsychiatrist.
For some, this seemed to be because of availability: “There are no psy-
chiatrists interested in dissociative seizures locally.”
Doctors were asked to report their usual approach to following up
patients with dissociative seizures before, during and since their in-
volvement in the CODES study (Table 2). While at a group level, in-
volvement in the CODES study did not seem to change follow-up
practice, 26% of doctors explained that the study had changed their
practice in relation to dissociative seizures in other ways. Common
changes made were: holding more structured or detailed discussions
with the patient (“I have seen a number of success stories and this has
changed my approach to communicating and referrals”), greater sign-
posting and information provision, using the CODES factsheet booklet,
making direct referrals for psychological intervention, and making
more referrals to other professionals.
While respondents did not report feeling more confident in mana-
ging patients with dissociative seizures overall, some doctors did ex-
press greater confidence in particular areas, for instance, saying that
they felt more confident when exploring factors associated with the
cause of dissociative seizures with the patient, and having gained more
confidence in making and communicating the diagnosis without stigma.
3.4. CODES trial-related elements
Over 69% of doctors agreed that patient satisfaction for the psy-
chiatric care and CBT developed for the CODES study was ‘very good’
(Table 3). Overall, 90% indicated they would like the pathway devel-
oped for the CODES study patients to continue within their service.
Some data challenged the negative stereotypes commonly held about
consulting with and treating patients with dissociative seizures; the vast
majority (83.7%) of neurologists agreed that they found it easy to re-
cruit patients with dissociative seizures to the trial and that patients
appeared satisfied by being in the trial (> 69%). That said, keeping
patients with dissociative seizures engaged was more commonly asso-
ciated with ambivalence (34.9% neither agreed or disagreed), sug-
gesting an acknowledgement of the difficulty maintaining some pa-
tients’ engagement.
We asked doctors how useful they found different elements of the
CODES care pathway (Table 4). The majority found all resources ‘very’
or ‘extremely’ useful, particularly relating to CBT for those who re-
ceived it (> 85% of doctors).
Overall, 91% of doctors agreed that they would like to continue to
use the factsheet/ booklet on dissociative seizures with future patients
(0% of doctors disagreed) – one respondent explained: “I found the
online information and booklets to be extremely useful and often this in itself
would be of therapeutic benefit”.Moreover, 84% of respondents explained
‘often’ or ‘very frequently’ referring patients with dissociative seizures
to relevant websites e.g. www.neurosymptoms.org, www.
nonepilepticattacks.info.
When asked to provide any additional thoughts about the CODES
project, doctors indicated they were pleased that: the study generated
data of relevance to psychological intervention for dissociative seizures;
it has helped to raise understanding and awareness of dissociative sei-
zures; the pathway has meant patients avoided existing waiting lists as
well as providing much needed and quicker access to assessment or
treatment for dissociative seizures; it facilitated multi-centered colla-
boration which was perceived as “a lasting legacy of the trial”; and also
that it has raised questions as to how and by whom patients with dis-
sociative seizures should be treated. Two doctors wished for additional
clinical resources i.e. to meet the increased demand caused by the
CODES trial, while another explained the problems encountered by
patients having to travel long distances to receive care during the
CODES study.
Table 1
Referral practice before involvement in the CODES trial (n.b. respondents could endorse multiple response options).
Practice n
I referred patients with dissociative seizures to a psychiatrist / neuropsychiatrist/ neuropsychologist so that they could consider referring the patient for psychological
intervention
26
I recommended to the General Practitioner that the patient with dissociative seizures should be referred to psychological intervention 15
I referred patients directly to psychological intervention specific for dissociative seizures 13
I could not refer patients to psychological intervention specific for dissociative seizures 10
I referred patients with dissociative seizures directly to psychological intervention 7
I recommended to patients with dissociative seizures that they should self-refer to psychological intervention 5
I did not refer patients with dissociative seizures to psychological intervention 2
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4. Discussion
Although many neurologists fail to see the care of this patient group
as their responsibility beyond diagnosis [2,10] and perceive such in-
dividuals as “challenging” and “frustrating” to care for [7], it was
surprisingly easy to get a considerable number of neurologists
throughout the UK to contribute to recruitment for a trial of a novel
psychologically enhanced treatment pathway for dissociative seizures.
The results here suggest that, in this group of neurologists, the negative
attitudes toward individuals with the condition that emerges from
previous interview and questionnaire studies do not apply [7]. The
apparent resistance to involvement in the treatment of patients with
dissociative seizures may, at least in part, be due to a lack of available
treatment resources (including care pathways and information sheets)
and lack of confidence in delivering or discussing the diagnosis and
treatment options with patients, rather than a principled objection to
treating such patients or to psychological therapies as such.
Fourteen doctors agreed that, during the trial, they were more likely
to consider dissociative seizures as a potential diagnosis at an earlier
stage of the usual investigation process. This suggests that the lack of
access to treatment or awareness of the condition may actually be one
of the reasons for the diagnostic delays which have previously been
reported in patients with dissociative seizures [11,12].
Research has demonstrated that the reaction of patients with dis-
sociative seizures to the diagnosis and suggestion of psychological
treatment is strongly influenced by doctors’ explanations of dissociative
seizures [13]. While the doctors contributing to this study did not feel
more confident in recommending psychological intervention to patients
at the end of the trial, having an understanding of what the treatment
entails may influence what is discussed during consultations and allow
patients to have more of their questions answered and be given more
information, thereby reducing patients’ apprehensions about the next
steps of care.
Over 90% of doctors who participated in this study agreed that they
would like the care pathway to continue within their service, with at
least one-third explaining that they had changed their practice towards
patients with dissociative seizures following their participation in the
CODES trial, for instance by making more referrals to other profes-
sionals or directly to psychological intervention and having more
structured and fruitful discussions with patients about their diagnosis.
Most doctors found different elements of the CODES study useful, more
specifically: the patient factsheet booklet (98%), diagnosis commu-
nication advice (93%), the CBT package (93%), neurological follow-up
(84%), and psychiatric assessment (72%). The majority (83.7%) of re-
spondents found it easy to recruit for the trial and felt that patient sa-
tisfaction for the psychiatric care and CBT treatment developed for the
CODES study was ‘very good’. Neurologist perception of satisfaction is
not the same as patient rated satisfaction. Nonetheless, this result is
striking in the context of previous studies generally painting a negative
picture of how hard neurologists find it to explain dissociative seizures
to patients [7,14] and motivate them to engage in psychological
treatment [6].
4.1. Limitations
The response rate for the online survey was moderate at 51% with
participants likely to have been biased towards neurologists with a keen
interest in the condition or study. As participants’ responses were
anonymous we are unable to differentiate between subgroups of re-
spondents; for example, many neurologists only referred a single pa-
tient into the CODES study so their responses were based on limited
experience. Our results are based entirely on neurologists’ self-report
and may not reflect, for example, how well the explanation of the di-
agnosis was received by patients in practice. Other publications about
the CODES trial (using quantitative and qualitative methods) will pro-
vide complimentary insights.
4.2. Conclusions
There is growing interest in exploring the attitudes of healthcare
professionals towards dissociative seizures. We are encouraged by the
finding that we were able to recruit 43 neurologists in the UK who self-
reported a good understanding of dissociative seizures, felt confident
treating and recruiting individuals into a treatment trial for dissociative
Table 2
Usual follow-up practice for patients with dissociative seizures (n.b. doctors could endorse multiple response options).
Before During Since
No follow-up provided 5.8%
(n= 4)
4.3% (n= 3) 3.1% (n=2)
Only follow-up for additional neurological comorbidities 21.7% (n=15) 20% (n=14) 17.2% (n=11)
Until patient has some confidence in and accepts diagnosis 30.4% (n=21) 25.7% (n=18) 28.1% (n=18)
Until dissociative seizures are controlled 4.3%
(n= 3)
10% (n=7) 10.9% (n=7)
Until AED is withdrawn 20.3% (n=14) 20% (n=14) 18.8% (n=12)
Until dissociative seizures are controlled and AED is withdrawn 11.6% (n=8) 10% (n=7) 12.5% (n=8)
Other 5.8%
(n= 4)
10%
(n=7)
9.4% (n=6)
AED=Anti-Epileptic Drug.
Table 3
Opinions regarding CODES study components.
Strongly Agree Agree Neither Disagree Strongly Disagree Not Sure
Very good patient satisfaction for the psychiatric care 30.2% (n= 13) 39.5% (n=17) 14% (n=6) 4.7% (n= 2) 2.3% (n= 1) 9.3% (n=4)
Very good patient satisfaction for CBT developed for CODES 27.9% (n=12) 51.2% (n=22) 9.3% (n= 4) 2.3% (n= 1) 0%
(n=0)
9.3% (n=4)
Would like the pathway to continue 60.5% (n=26) 30.2% (n=13) 9.3% (n= 4) 0%
(n=0)
0%
(n=0)
–
Easy to recruit patients 39.5% (n= 17) 44.2% (n=19) 11.6% (n=5) 2.3% (n= 1) 2.3% (n= 1) –
Easy to keep patients with dissociative seizures engaged in CODES 14% (n=6) 48.8% (n=21) 34.9% (n=15) 2.3% (n= 1) 0%
(n=0)
–
CBT=Cognitive Behavioural Therapy.
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seizures and who (for the most part) provided follow-up. The partici-
pating doctors reported diagnosing a median of three patients a month
with dissociative seizures; however, before and after the trial, only
about one-half could make direct referrals to psychological intervention
specific for dissociative seizures. Our results demonstrate that neurol-
ogists find additional resources such as a patient factsheet booklet and
diagnosis communication advice (as well as a clear management
pathway) useful when providing care for individuals with dissociative
seizures. The vast majority of neurologists who responded to our online
survey reported wanting the treatment pathway developed for the
CODES trial to continue within their service, demonstrating their in-
terest in taking on an active role in the management of dissociative
seizures. While the results suggest that progress is being made, the fact
that many neurologists participating in the CODES study lost the ability
to offer patients psychotherapy again after the end of the study re-
cruitment period means that problems with lack of access to psycho-
logical treatment for dissociative seizures persist.
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Table 4
Usefulness of elements of the CODES study.
Extremely Very Moderately Slightly Not at all Not aware
Diagnosis communication advice for neurologists 18.6% (n= 8) 53.5% (n=23) 18.5%
(n=8)
2.3% (n= 1) 4.7% (n= 2) 2.3%
(n=1)
Patient fact sheet/booklet 48.8% (n= 21) 32.6% (n=14) 14%
(n=6)
2.3% (n= 1) 0% (n=0) 2.3%
(n=1)
Psychiatric assessment 34.9% (n= 15) 44.2% (n=19) 16.3%
(n=7)
0% (n=0) 0% (n=10) 4.7%
(n= 2)
Neurological follow-up 7%
(n=3)
46.5% (n=20) 20.9%
(n=9)
9.3% (n= 4) 4.7% (n= 2) 11.6% (n=5)
CBT for those who received it 34.9% (n= 15) 51.2% (n=22) 4.7%
(n=2)
2.3% (n= 1) 0% (n=0) 7%
(n=3)
CBT=Cognitive Behavioural Therapy.
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